// App-Quantinova.ai

895 : COVID-19 Vaccination in Autoimmune Diseases Study: Vaccine Safety in Rheumatoid Arthritis

Researchers

Presenter

  • Naveen R

Principal Investigators

  • Mrudula Joshi

  • Parikshit Sen

  • Minchul Kim

  • Vishwesh Agarwal

  • Sinan Kardes

  • James B. Lilleker

  • Hector Chinoy

  • Oliver Distler

  • Ai Lyn Tan

  • Samuel Shinjo

  • Babur Salim

  • Tamer A Gheita

  • Nelly Ziade

  • Tsvetelina Velikova

  • Tulika Chatterjee

  • Arvind Nune

  • Marcin Milchert

  • Abraham Edgar Gracia-Ramos

  • Albert Selva O’Callaghan

  • Miguel Angel Saavedra Salinas

  • Lorenzo Cavagna

  • Masataka Kuwana

  • Johannes Knitza

  • Jessica Day

  • Ashima Makol

  • John Pauling

  • Chris Wincup

  • Erick Zamora Tehozol

  • Jorge Rojas Serrano

  • Ignacio Garcia-De La Torre

  • Rohit Aggarwal

  • Vikas Agarwal

  • Latika Gupta

  • Elena Nikiphorou

Medical Centers

  • Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India

  • Karolinska Institutet, Stockholm, Sweden

  • Byramjee Jeejeebhoy Government Medical College And Sassoon General Hospital, Pune, India

  • Maulana Azad Medical College, New Delhi, Delhi, India

  • Univ. of Illinois College of Med. at Peoria, Peoria, IL.

  • Mahatma Gandhi Missions Medical College, Lucknow, India

  • Istanbul University, Istanbul, Turkey

  • University of Manchester, Manchester, United Kingdom

  • The University of Manchester, Salford, United Kingdom

  • Department of Neuroradiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland

  • University of Leeds, Leeds, United Kingdom

  • ICESP Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil

  • Fauji foundation hospital Rawalpindi, Rawalpindi, Pakistan

  • Rheumatology Department, Faculty of Medicine, Al-Azhar Univerist, Cairo, Egypt

  • Saint Joseph University, Beirut, Lebanon

  • Sofia University St. Kliment Ohridski, Sofia, Bulgaria

  • Southport and Ormskirk Hospital NHS Trust, Southport, UK

  • Pomeranian Medical University, Szczecin, Poland

  • Instituto Mexicano del Seguro Social, Mexico DF, Mexico

  • Hospital Universitario del Mar, Barcelona, Spain

  • IMSS, México, Ciudad de México, Mexico

  • University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

  • Nippon Medical School Graduate School of Medicine, Tokyo, Japan

  • Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, 91054 Erlangen, Germany; Deutsches Zentrum Immuntherapie, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany

  • Walter and Eliza Hall Institute, Northcote, Australia

  • Mayo Clinic, Rochester, Rochester, MN

  • North Bristol NHS Trust, Bristol, United Kingdom

  • UCL Cancer Institute, University College London,, London, United Kingdom

  • Centro Medico Pensiones, Merida, Mexico

  • Hospital Angeles Villahermosa, Ciudad de México, Mexico

  • Centro de Est. de Inv. Bas. y Clinica, S.C., Guadalajara, Mexico

  • Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA

  • Royal Wolverhampton Trust, Wolverhampton/University of Manchester, United Kingdom

  • Leiden University Medical Center & King's College London, London, United Kingdom

  • CoVAD study group, Wolwehampton, United Kingdom

Locations

  • India

  • Sweden

  • United States

  • Turkey

  • United Kingdom

  • Switzerland

  • Brazil

  • Pakistan

  • Egypt

  • Lebanon

  • Bulgaria

  • Poland

  • Mexico

  • Spain

  • Italy

  • Japan

  • Germany

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Infectious Diseases (ID)

Disease

  • Rheumatoid arthritis

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A